Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Comment by juanonaon Feb 20, 2008 3:42pm
363 Views
Post# 14401897

RE: BNN today on market call

RE: BNN today on market callThanks for the heads up. I listened to his comments and here's what I wrote on the board at SI: Rob McWhirter was on BNN today (11:30 small cap segment). A caller asked him about VRS. He said they still own shares (but aren't buying any more at this point). Year End is Sept and he expects VRS to earn .69 vs .14 last year for a PE of 6. Significant upside to the stock. Market was spooked by CREW3, but the company will be bringing out technology in the next 6 months that leapfrogs existing capabilities. Market waiting for confirmation of future orders/backlog which may not happen for another 3-4 months. His firm is not currently buying more, watching the stock; technically it is important that it hold $4 Luxton also mentioned the enhanced technical capabilities in the cc last week. Called it a 'very advanced, single, multi-purpose platform extending well beyond jamming.' He also noted their own R&D was outpacing gov't R&D by which I believe he was referring to the CREW3 development awards. If we get the backlog replenished, followed by updates on the technolgy front, we should be back on an upward track later in the year IMHO.
Bullboard Posts